FTC Can't Weigh In On Effexor Authorized Generics Case

Law360, New York (October 4, 2012, 6:53 PM EDT) -- A New Jersey federal judge refused Wednesday to let the Federal Trade Commission weigh in on private antitrust litigation targeting an authorized generic deal between Wyeth LLC and Teva Pharmaceuticals USA Inc., ruling the agency's partiality made it an ill-suited amicus.

U.S. District Judge Joel A. Pisano denied the FTC's request to file an amicus brief in the suit over generic versions of Wyeth's antidepressant Effexor XR. The FTC had argued a branded company's pledge not to launch an authorized generic in competition with a generic...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.